NCCN Academy


NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business


This Virtual Program was held on March 25, 2021. 

During this interactive online program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.



Clifford gOODMAN

Clifford Goodman, PhD
Senior Vice President
The Lewin Group


12:00 – 12:05 PM



Beth Gaffney, MBA
Vice President, US & Global Business Development
National Comprehensive Cancer Network


12:05 – 1:30 PM


Module I: Meet the Guidelines Panel Experts

Clifford Goodman, PhD
Senior Vice President
The Lewin Group

Deborah Armstrong, MD
Professor of Oncology,

Professor of Gynecology and Obstetrics
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Shaji Kumar, MD
Consultant, Division of Hematology,

Professor of Medicine,
Medical Director, Cancer Center Research Office
Mayo Clinic Cancer Center

Gregory Riely, MD, PhD
Vice Chair, Clinical Research, Department of Medicine
Memorial Sloan Kettering Cancer Center


1:30 – 1:45 PM


1:45 – 2:55 PM


Module II: Future of the Affordable Care Act

Justin Bekelman, MD
Professor; Director, Penn Center for

Cancer Care Innovation
Abramson Cancer Center at the University of Pennsylvania

Ezekiel J. Emanuel, MD, PhD
Chair, Medical Ethics and Health Policy
Abramson Cancer Center at the University of Pennsylvania

Marc Samuels, JD, MPH
Chief Executive Officer

Phylicia Woods, JD, MSW
Executive Director, Cancer Policy Institute
Cancer Support Community

2:55 – 3:00 PM


Closing Remarks

Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer
National Comprehensive Cancer Network


*Curriculum subject to change. All times are EDT, see World Clock here.


Intended Audience

Professionals from advocacy, marketing, medical affairs, clinical research, policy and government affairs, and other business areas will better be able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.


View Past Academy Programs

Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.

View the Virtual Academy Program held on June 29, 2020.

Customize your own NCCN Academy curriculum.

NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.